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Abstract
Background: The	extent	of	 transmission	of	 influenza	 in	hospital	 settings	 is	poorly	
understood.	Next	generation	sequencing	may	improve	this	by	providing	information	
on	the	genetic	relatedness	of	viral	strains.
Objectives: We	aimed	to	apply	next	generation	sequencing	to	describe	transmission	
in	hospital	and	compare	with	methods	based	on	routinely‐collected	data.
Methods: All	influenza	samples	taken	through	routine	care	from	patients	at	University	
College	London	Hospitals	NHS	Foundation	Trust	(September	2012	to	March	2014)	
were	 included.	We	conducted	 Illumina	 sequencing	and	 identified	genetic	 clusters.	
We	 compared	 nosocomial	 transmission	 estimates	 defined	 using	 classical	methods	
(based	on	time	from	admission	to	sample)	and	genetic	clustering.	We	identified	pairs	
of	cases	with	space‐time	links	and	assessed	genetic	relatedness.
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1  | BACKGROUND
Nosocomial	influenza	is	associated	with	increased	length	of	hospital	
stay,	severe	complications	and	death.1	The	extent	of	transmission	in	
hospital	settings	is	poorly	understood,	however,	because	identifica‐
tion	of	transmission	events	is	challenging.	Classical	methods	assume	
cases	 to	be	 “hospital‐acquired”	when	 the	 time	between	admission	
and	the	first	positive	sample	exceeds	the	 incubation	period	of	 the	
influenza	 virus.	 This	 definition	 is	 not	 always	 accurate	 as	 the	 incu‐
bation	period	is	variable	(0.7	to	2.8	days),2	early	symptoms	may	not	
be	recorded	or	recognised	as	 influenza,	samples	may	not	be	taken	
at	consistent	time	points	within	an	illness,	and	systems	often	fail	to	
capture	information	on	hospital	contact	prior	to	admission.
Next	generation	sequencing	methods	have	the	potential	to	im‐
prove	the	precision	of	these	inferences	by	providing	information	on	
the	genetic	relatedness	of	viral	strains.3	Genetic	approaches	use	as‐
sumptions	about	the	rate	at	which	the	virus	acquires	mutations	and	
the	likely	duration	of	an	outbreak	to	assess	whether	direct	links	be‐
tween	patients	are	plausible.	Availability	of	near	real‐time	sequenc‐
ing	data	therefore	raises	the	opportunity	for	improved	surveillance	
through	 earlier	 identification	 of	 outbreaks	 and	more	 effective	 re‐
sponse.	 Used	 retrospectively,	 information	 derived	 from	 next	 gen‐
eration	 sequencing	may	also	 inform	policy	and	practice	 for	 future	
outbreaks.
Previous	 applications	 of	 next	 generation	 sequencing	 of	 influ‐
enza	have	included	elucidating	zoonosis	and	describing	transmission	
of	 seasonal	 and	pandemic	 strains.3‐6	 In	 the	 context	of	nosocomial	
transmission,	several	studies	have	used	next	generation	sequencing	
to	assess	differences	between	sequences	of	 specific	 influenza	ge‐
nome	 segments	 (HA,	NA	 and/or	 PB2)	 or	 to	 investigate	 small	 out‐
breaks.7‐18	These	results	have	highlighted	the	importance	of	multiple	
introductions	of	community	strains.	Whole	genome	sequencing	has	
been	used	 in	other	studies	to	demonstrate	that	 isolates	 in	pre‐de‐
fined	 epidemiological	 clusters	 are	 more	 likely	 to	 be	 related	 than	
those	 outside	 of	 such	 clusters	 and	 to	 differentiate	 outbreaks	 into	
clusters.19‐21	However,	we	are	unaware	of	studies	using	the	greater	
resolution	afforded	by	next	generation	sequencing	of	the	entire	ge‐
nome	to	explore	nosocomial	transmission	of	influenza	across	whole	
seasons.	 Implementation	 of	 next	 generation	 sequencing	 has	 also	
been	 limited	by	 lack	of	 analytical	 capacity,	 absence	of	established	
quality	control	comparators	and	cost.22
In	this	study,	we	conducted	whole	genome	next	generation	se‐
quencing	on	all	samples	of	influenza	taken	at	a	large	teaching	hos‐
pital	 in	London	over	 two	winter	seasons.	We	aimed	 to	 investigate	
the	capability	of	 this	method	 to	enhance	 identification	of	hospital	
transmission	of	influenza	compared	to	methods	based	on	routinely	
collected	data	alone	and	to	describe	transmission	within	the	hospital	
setting.
2  | METHODS
2.1 | Study design and setting
This	 was	 a	 retrospective	 cross‐sectional	 study	 of	 patients	 at	
University	College	London	Hospitals	NHS	Foundation	Trust	(UCLH).	
UCLH	is	a	major	teaching	and	research	hospital	 in	central	London,	
which	has	approximately	900	beds,	sees	on	average	more	than	one	
million	 outpatients,	 has	 131	000	 accident	 and	 emergency	 attend‐
ances	and	admits	more	than	170	000	patients	each	year.23,24
All	 laboratory‐confirmed	 (PCR‐positive)	 influenza	 samples	
taken	between	13	September	2012	and	22	March	2014	were	in‐
cluded	in	the	study.	Samples	were	obtained	through	routine	care	
based	on	clinical	suspicion	of	influenza	(no	formal	case	definitions	
were	used	to	guide	sampling)	from	inpatient,	outpatient	and	emer‐
gency	 department	 settings.	 Patient	 demographics	 (age	 and	 sex),	
and	 dates	 of	 positive	 samples,	 admission,	 discharge	 and	 trans‐
fer	between	hospital	wards	were	extracted	 retrospectively	 from	
electronic	 records.	 Samples	 from	 the	 same	 patient	 taken	within	
Results: We	sequenced	influenza	sampled	from	214	patients.	There	were	180	unique	
genetic	 strains,	 16	 (8.8%)	 of	which	 seeded	 a	 new	 transmission	 chain.	 Nosocomial	
transmission	was	indicated	for	32	(15.0%)	cases	using	the	classical	definition	and	34	
(15.8%)	based	on	genetic	clustering.	Of	the	50	patients	in	a	genetic	cluster,	11	(22.0%)	
had	known	space‐time	links	with	other	cases	in	the	same	cluster.	Genetic	distances	
between	pairs	of	cases	with	space‐time	links	were	lower	than	for	pairs	without	spatial	
links	(P	<	.001).
Conclusions: Genetic	data	confirmed	that	nosocomial	transmission	contributes	sig‐
nificantly	 to	 the	 hospital	 burden	 of	 influenza	 and	 elucidated	 transmission	 chains.	
Prospective	next	generation	sequencing	could	support	outbreak	investigations	and	
monitor	the	impact	of	infection	and	control	measures.
K E Y W O R D S
cross	infection,	disease	outbreaks,	influenza,	human,	molecular	epidemiology
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a	14‐day	period	were	assumed	to	be	a	continuation	of	 the	same	
illness.
2.2 | Next generation sequencing and 
phylogenetic analysis
RNA	 was	 extracted	 from	 residual	 diagnostic	 specimens	 and	 se‐
quenced	using	Illumina	MiSeq	paired‐end	sequencing	as	previously	
described.4	 Full	 details	 of	 phylogenetic	 methods	 are	 provided	 in	
the	supplementary	appendix.	In	summary,	we	generated	consensus	
sequences	 from	 short	 reads	 using	 an	 in‐house	 de	 novo	 assembly	
pipeline,	applying	a	read	depth	cut‐off	of	≥20	reads	to	the	final	se‐
quences.	 Sets	 of	 segments	were	 compiled	 after	 categorising	 sam‐
ples	by	lineage	(A/(H1N1)	pdm09,	A/H3N2,	B/Yamagata)	and	season	
(2012‐13,	 2013‐14).	 Maximum‐likelihood	 phylogenetic	 trees	 were	
inferred	for	each	alignment.
We	defined	genetic	distance	as	 the	number	of	pairwise	nucle‐
otide	differences	between	aligned	sequences	of	the	same	subtype	
and	within	the	same	season.	The	maximum	expected	number	of	sub‐
stitutions	between	pairs	of	samples	was	calculated	using	the	upper	
bound	of	the	95%	credibility	interval	of	the	rate	of	substitution	and	
sequencing	 error	 rate	 for	 each	 season	 and	 lineage,	 assuming	 an	
upper	 limit	of	20	days	between	transmission	pairs	and	normalising	
for	pairwise	alignment	length	(see	Table	S2	for	rates	of	substitution	
and	sequencing	error).
We	defined	genetic	clusters	as	viral	genomes	that	differed	by	
less	 than	 the	 maximum	 expected	 number	 of	 nucleotide	 substi‐
tutions	 obtained	 from	 samples	 collected	within	 20	days	 of	 each	
other.	We	 calculated	 the	 number	 of	 distinct	 genetic	 strains,	 the	
proportion	of	cases	that	seeded	a	new	transmission	chain	(ie	clus‐
ters	 of	 at	 least	 two	 cases)	 and	 the	median	 number	 of	 cases	 per	
cluster.
2.3 | Identification of nosocomial transmission
We	identified	potential	instances	of	nosocomial	transmission	using	
a	classical	method	(based	on	routinely	collected	hospital	data	only)	
and	a	genetic	method	(using	results	from	next	generation	sequenc‐
ing).	In	the	“classical”	method,	we	defined	cases	as	hospital‐acquired	
if	the	positive	sample	was	taken	more	than	two	days	after	admission	
and	 as	 community‐acquired	 if	 taken	within	 2	 days.	We	 calculated	
the	proportion	assumed	to	be	nosocomially	acquired	using	the	for‐
mula:	number	of	cases	with	the	first	positive	sample	taken	more	than	
2	days	after	admission/	total	number	of	cases.
In	the	“genetic”	method,	we	considered	that	cases	within	the	
same	 genetically	 defined	 cluster	 were	 linked	 through	 transmis‐
sion.	We	 calculated	 the	 proportion	 assumed	 to	 be	 nosocomially	
acquired	using	the	formula:	(number	of	cases	in	genetic	clusters	–	
number	of	unique	genetic	clusters)/	number	of	cases.	This	assumes	
that	each	genetic	cluster	has	one	community‐acquired	index	case.
We	 hypothesised	 that	 cases	 in	 this	 hospital	 classified	 as	 hos‐
pital‐acquired	by	the	genetic	definition	would	be	more	likely	to	be	
hospital‐	 than	 community‐acquired	 (according	 to	 the	 “classical”	
definition).	We	therefore	calculated	the	proportions	 in	each	group	
and	compared	them	using	Fisher's	exact	test.
2.4 | Identification of space‐time links
We	 sought	 to	 establish	 the	 extent	 to	which	 pairs	 of	 cases	with	
space‐time	 links	 based	 on	 dates	 and	ward	 locations	 also	 shared	
genetic	 links.	 We	 identified	 space‐time	 links	 between	 pairs	 of	
cases	 with	 the	 same	 influenza	 subtype	 based	 on	 their	 assumed	
infectious	 and	 “acquisition”	 periods	 (Figure	 S1).	 The	 acquisition	
period	was	the	period	in	which	they	may	have	been	infected	and	
was	derived	 from	 the	 incubation	period	 (1‐3	days)	 plus	 an	 inter‐
val	(0‐2	days)	between	onset	of	symptoms	and	sample	collection.2 
Acquisition	 periods	 therefore	 ranged	 from	 1	 to	 5	 calendar	 days	
prior	to	the	sample	collection	date.	We	considered	acquisition	to	
be	possible	in	the	hospital	ward	where	the	sample	was	taken	and	
all	wards	where	the	patient	was	treated	during	the	assumed	acqui‐
sition	period.	We	defined	the	infectious	period	as	lasting	a	maxi‐
mum	of	14	days	starting	from	two	days	before	the	sample	date.25 
We	also	conducted	sensitivity	analyses	varying	the	length	of	the	
infectious	period	(Appendix	S1).
Pairs	of	cases	were	classified	as	having	space‐time	links	if	they	
had	 the	 same	 influenza	 subtype	 and	 overlapping	 infectious	 and	
acquisition	periods	whilst	 in	 the	 same	hospital	 location.	We	cal‐
culated	the	proportion	of	cases	in	genetic	clusters	that	had	space‐
time	 links	with	 cases	 in	 the	 same	 genetic	 cluster	 (and	 therefore	
also	 of	 the	 same	 influenza	 subtype).	We	 also	 hypothesised	 that	
pairs	of	cases	with	space‐time	links	would	have	closer	genetic	links	
than	pairs	of	cases	that	were	linked	temporally	(ie	by	overlap	in	in‐
fectious	and	acquisition	periods)	but	did	not	have	spatial	co‐occur‐
rence.	Time‐linked	cases	were	used	for	this	comparison	to	account	
for	 the	accumulation	of	 independent	genetic	 changes	over	 time.	
We	investigated	this	by	comparing	the	genetic	distances	(regard‐
less	of	cluster	assignment)	amongst	these	pairs	of	cases	with	the	
Wilcoxon	rank‐sum	test.
Finally,	we	combined	epidemiological	and	genetic	data	to	visu‐
alise	potential	transmission	links.	Data	were	managed,	analysed	and	
visualised	using	Stata	v14	and	R	v3.5.0.
2.5 | Ethical approval
REC	 approval	 (13/LO/1303)	 for	 ICONIC	 was	 received	 on	 20th	
August	2013,	IRAS	project	ID	131373.	Approval	applies	to	all	NHS	
sites	taking	part	in	the	study	and	additional	permissions	have	been	
obtained	from	the	NHS/HSC	R&D	offices	of	all	partner	sites	prior	to	
the	start	of	the	study.
3  | RESULTS
A	total	of	332	PCR‐positive	influenza	samples	were	identified	dur‐
ing	the	study	period.	Full	genome	sequencing	was	possible	for	242	
(72.9%)	samples,	from	214	patients.	It	is	likely	that	sequencing	was	
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not	 successful	 for	 the	 remaining	 samples	 due	 to	 insufficient	 viral	
load.	All	 subsequent	analyses	are	based	on	 the	samples	 for	which	
sequencing	was	successful.	The	characteristics	of	the	patient	popu‐
lation	are	shown	in	Table	1.
Phylogenetic	trees	for	each	influenza	subtype	(influenza	A	H3N2,	
influenza	A	(H1N1)	pdm09	and	influenza	B	Yamagata‐like)	are	shown	
in	the	appendix	(Figure	S2).	There	were	180	unique	strains,	of	which	
16	(8.9%,	approximately	1	in	11)	seeded	a	new	transmission	chain.	
The	remaining	164	strains	did	not	cluster	with	other	cases.	The	16	
genetic	clusters	included	50	patients	in	total,	with	a	median	cluster	
size	of	3	(range	2‐5).	Although	not	a	pre‐requisite	for	forming	clus‐
ters,	 the	majority	 (44/50)	of	clustered	samples	were	supported	by	
a	bootstrap	confidence	value	of	greater	than	75%	in	the	phylogeny	
and	42/50	by	a	value	of	greater	than	90%.
Using	the	classical	definition	of	nosocomial	transmission,	15.0%	
(32/214)	cases	were	classified	as	hospital‐acquired	(tested	positive	
for	influenza	more	than	two	days	after	admission).	Using	the	genetic	
definition,	15.8%	(34/214)	cases	were	classified	as	due	to	nosoco‐
mial	 transmission	 (50	 cases	 in	 genetic	 16	 clusters,	 16	 index	 cases	
assumed	to	be	 introduced	from	community	and	34	due	to	onward	
transmission).	 The	 concordance	between	 these	methods	 is	 shown	
in	 Table	 2:	 The	 hospital‐acquired	 cases	 (according	 to	 the	 classical	
definition)	were	more	likely	to	be	classified	as	hospital‐acquired	by	
the	genetic	method	(19/32,	59.4%)	than	community‐acquired	cases	
(31/182,	17.0%,	P	<	.001).
Of	the	50	cases	 in	genetic	clusters,	11	 (22.0%)	had	space‐time	
links	(based	on	routinely	collected	data)	with	other	cases	in	the	same	
genetic	cluster.	Genetic	distances	between	pairs	of	cases	that	had	
space‐time	links	were	smaller	(median	1.8	×	10−3	substitutions/site,	
interquartile	 range	0.7‐3.1)	 than	between	pairs	of	cases	 that	were	
linked	in	time	only	(5.1	×	10−3	substitutions/site,	interquartile	range	
2.5‐8.1,	P	<	.001;	Figure	1).
Space‐time	 and	 genetic	 links	 between	 cases	 (first	 sample	 per	
person	only)	are	displayed	visually	for	the	2012‐2013	influenza	sea‐
son	in	Figure	2.	This	figure	highlights	that	cases	(dots)	with	genetic	
links	(black	lines)	are	frequently	sampled	on	the	same	ward	(colour	
of	dot)	at	around	the	same	time.	It	also	shows	instances	where	trans‐
mission	links	may	have	been	presumed	(patients	on	the	same	ward	at	
around	the	same	time,	eg	cases	in	rectangle),	but	genetic	data	show	
the	cases	are	not	part	of	the	same	transmission	chain.
4  | DISCUSSION
We	have	 used	whole	 genome	 sequencing,	 on	 an	 established	 next	
generation	 sequencing	 platform,	 to	 investigate	 nosocomial	 spread	
of	influenza	across	two	winter	seasons.	Based	on	genetic	data,	we	
found	that	one	in	eleven	cases	of	influenza	introduced	to	a	hospital	
seeded	a	new	transmission	chain.	This	resulted	in	an	average	of	three	
instances	of	presumed	onward	transmission,	with	at	least	16%	of	the	
total	cases	of	influenza	in	the	hospital	due	to	nosocomial	transmis‐
sion.	Cases	resulting	from	these	presumed	transmission	events	were	
more	likely	to	meet	the	classical	definition	of	nosocomial	 infection	
TA B L E  1  Characteristics	of	patients	with	influenza	samples	
sequenced	by	full	genome	sequencing,	University	College	London	
Hospitals	NHS	Foundation	Trust,	2012‐2014	(n	=	214)
 Number of patients %
Total 214 –
Gender
Male 120 56.1
Female 94 43.9
Age group (y)
<5 38 17.8
5‐14 18 8.4
15‐64 119 55.6
65+ 39 18.2
Sample collection date
September	2012‐August	
2013
183 85.5
September	2013‐March	
2014
31 14.5
Sample collection location
Inpatient	ward 115 53.7
Outpatient	clinic 23 10.7
Accident	and	Emergency 76 35.5
Duration of hospital admission (amongst 132 admitted patients, d)
Median 5 –
Interquartile	range 5‐12 –
Influenza subtype
A	H3N2 82 38.3
A	H1N1 52 24.3
A 18 8.4
B 62 29.0
TA B L E  2  Evidence	for	nosocomial	transmission	of	influenza	
using	classical	and	genetic	methods,	University	College	London	
Hospitals	NHS	Foundation	Trust,	2012‐2014	(n	=	214)
Classical definitiona
Genetic definitionb
Hospital‐acquired 
(n = 34)
Community‐ac‐
quired (n = 180)
n %c n %
Hospital‐acquired	
(n	=	32)
14 43.8 18 56.3
Community‐acquired	
(n	=	182)
20 11.0 162 89.0
aCases	defined	as	hospital‐acquired	if	PCR‐positive	influenza	sample	
was	taken	more	than	two	days	after	admission;	and	as	community‐ac‐
quired	if	taken	within	two	days.	
bCases	defined	as	hospital‐acquired	if	they	were	part	of	a	genetically	
defined	cluster	(except	the	first	case	to	be	identified	in	the	cluster,	
classified	as	the	“index”	case);	and	as	community‐acquired	if	they	were	
index	cases	or	had	unique	genetic	strains.	
cRow	percentages	
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(occurring	 two	 or	more	 days	 after	 admission	 to	 the	 hospital	 than	
within	two	days),	(P	<	.001).	This	supports	the	capability	of	virus	ge‐
netics	to	be	used	to	identify	nosocomial	transmission.
Our	estimate	of	the	extent	of	nosocomial	transmission	based	on	
the	classical	method	(15%)	was	similar	to	previous	estimates	in	UK	
settings,	which	defined	nosocomial	infection	based	on	presentation	
of	symptoms	3‐4	days	after	hospital	admission	and	gave	estimates	of	
nosocomial	infection	of	2%‐12%.1,26	Although	our	estimate	derived	
using	genetic	clustering	produced	a	similar	value	(16%),	there	was	a	
lack	of	concordance	between	the	two	methods.	Only	14/32	(44%)	
cases	 classified	 as	 hospital‐acquired	by	 the	 classical	method	were	
classified	as	hospital‐acquired	using	the	genetic	method,	and	14/34	
(41%)	 cases	 classified	 as	 hospital‐acquired	 by	 the	 genetic	method	
were	hospital‐acquired	 according	 to	 the	 classical	method.	 The	 ac‐
curacy	of	the	classical	method	is	 limited	by	lack	of	symptom	onset	
information	and	variation	in	sampling	practice.	For	example,	if	a	pa‐
tient	has	symptoms	of	influenza	when	they	are	admitted	to	hospital,	
but	are	not	sampled	within	two	days,	they	would	be	incorrectly	clas‐
sified	as	having	hospital‐acquired	infection,	but	may	be	shown	not	
to	be	in	a	genetic	cluster	leading	to	discordant	results.	The	genetic	
method	does	not	rely	on	these	assumptions,	and	can	establish	direct	
transmission	links	between	cases,	and	is	therefore	likely	to	be	more	
reliable.	It	is	also	possible	that	cases	classified	as	hospital‐acquired	
by	 the	genetic	method	within	 two	days	of	admission	were	part	of	
community	clusters,	but	this	is	unlikely	given	the	diversity	of	com‐
munity	strains.
Pairs	of	cases	that	had	space‐time	links	(derived	from	dates	and	
ward	 locations	 recorded	 in	 routine	 hospital	 data)	 had	 smaller	 ge‐
netic	distances	than	those	without	space‐time	links	(P	<	.001).	This	
indicates	 closer	 genetic	 relatedness	 and	 is	 consistent	with	 studies	
in	household,	hospital	and	 long‐term	care	facility	settings.19,20,27‐29 
However,	only	22%	of	cases	in	genetic	clusters	had	space‐time	links	
with	other	cases	in	the	same	genetic	cluster.	This	implies	that	most	
transmission	 is	 not	 through	 obvious	 ward‐based	 contact.	 Genetic	
clustering	analysis	could	therefore	be	useful	to	distinguish	genuine	
outbreaks	 from	coincidental	pairs	of	cases	on	wards	and	 to	direct	
control	efforts	accordingly.
This	study	aimed	to	describe	how	virus	genomics	could	improve	
understanding	 of	 nosocomial	 transmission	 gleaned	 from	 routine	
hospital	data	and	clinical	practice.	As	such,	there	was	no	enhanced	
sampling	 or	 epidemiological	 investigation	 to	 identify	 potential	 in‐
teractions	 between	 patients	 outside	 ward	 settings.	 Results	 will	
therefore	have	been	based	on	incomplete	case	ascertainment,	and	
transmission	 occurring	 on	 non‐ward	 settings,	 from	 sub‐clinically	
infected	patients,	staff	members	or	visitors	could	not	be	detected.	
This	 demonstrates	 an	 advantage	 of	 using	 sequencing	 data,	 which	
can	 group	 cases	 into	 genetic	 clusters	 even	 if	 some	of	 the	 links	 in	
the	transmission	chain	are	missing.	Enhanced	sampling	of	patients,	
staff	and	visitors	to	identify	all	cases	and	prospective	collection	of	
contact	data	would	likely	be	needed	to	establish	evidence	of	contact	
between	 a	 greater	 proportion	 of	 genetically	 clustered	 cases	 than	
was	possible	using	retrospective	patient	ward	movement	data.
A	 limitation	of	our	analysis	 is	that	we	did	not	have	information	
on	symptoms,	co‐morbidities	or	clinical	outcomes	such	as	length	of	
stay.	We	therefore	could	not	estimate	which	of	 these	factors	may	
have	influenced	transmission	or	severity	of	illness.	We	also	did	not	
have	data	on	negative	tests	for	influenza	and	were	therefore	unable	
to	ascertain	 if	 individuals	were	tested	before	their	positive	sample	
F I G U R E  1  Normalised	genetic	
distances	between	pairs	of	influenza	
H1N1	and	H3N2	cases	that	were	linked	
in	time	and	space,	University	College	
London	Hospitals	NHS	Foundation	Trust,	
2012‐2014	(n	=	134).	Time	only:	Links	
between	cases	based	on	overlapping	
assumed	infectious	and	acquisition	
periods	only.	Space‐time:	Links	between	
cases	based	on	overlapping	assumed	
infectious	and	acquisition	periods	whilst	in	
the	same	hospital	location
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was	taken.	However,	 the	 infection	control	policy	 in	this	hospital	 is	
to	isolate	all	patients	presenting	with	influenza‐like	illness	on	admis‐
sion	until	results	of	PCR	testing	are	known.	Another	limitation	was	
the	definition	of	genetic	clusters,	which	was	based	on	small	differ‐
ences	between	genomes	and	would	therefore	be	sensitive	to	small	
variations	 in	sequences	and	sequencing	errors.	However,	the	anal‐
ysis	 based	on	 genetic	 distance	measures	 did	 not	 involve	 grouping	
isolates	 into	clusters.	This	analysis	showed	that	pairs	of	cases	had	
closer	genetic	relatedness	when	they	had	space‐time	links	and	sup‐
ports	 the	 findings	 from	cluster‐based	analyses.	A	previous	simula‐
tion	study	has	shown	that	the	expected	number	of	changes	between	
two	influenza	genomes	that	come	from	a	direct	transmission	event	
is	likely	to	be	0	or	1,	in	line	with	our	results.30
The	sequencing,	gene	assembly,	phylogenetic	and	epidemiolog‐
ical	analyses	presented	here	have	the	potential	to	be	automated	to	
provide	near	real‐time	(within	24‐48	hours)	pictures	of	transmission	
within	hospitals.	 If	 implemented	 in	multiple	 hospitals,	 both	 locally	
and	 internationally,	 the	estimates	could	be	used	 to	 inform	surveil‐
lance	 for	 comparison	 of	 influenza	 strains	 in	 circulation	 and	 their	
transmission	 potential.	 It	 could	 also	 be	 used	 for	 earlier	 identifica‐
tion	of	outbreaks,	 enabling	 introduction	of	more	 intensive	 control	
efforts.	 This	may	 include	 increased	 testing	 to	 identify,	 isolate	 and	
treat	cases	earlier,	cohorting,	enhanced	hand	hygiene,	engineering	
approaches	 to	 increase	 ventilation,	 use	 of	 respiratory	 protection	
and	vaccination	of	staff	or	vulnerable	patient	groups.	Analyses	such	
as	we	present	here	can	also	provide	accurate	numbers	to	measure	
changes	in	policy	or	prevention	and	for	ascertaining	best	practice	in	
different	health	care	settings.	For	example,	viral	genetic	sequencing	
could	be	used	to	assess	the	impact	of	healthcare	worker	vaccination	
and	visitor	infection	control	practices	on	the	extent	of	transmission.
In	 conclusion,	 our	 results	 demonstrate	 the	 value	 of	 routine	
whole	 genome	 sequencing	 to	 inform	 influenza	 surveillance	 and	
infection	 control	 interventions	 in	 hospitals.	 Genetic	 data	 con‐
firmed	nosocomial	 transmission	 for	approximately	16%	of	cases,	
with	 short	chains	of	 transmission.	These	 results	 suggest	 that	 in‐
tegrating	 next	 generation	 sequencing	 to	 real‐time	 investigations	
of	influenza	in	hospital	could	inform	strengthened	infection	con‐
trol	 measures	 to	 minimise	 the	 burden	 of	 nosocomially	 acquired	
infection.
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